125 related articles for article (PubMed ID: 15862804)
1. Agonism at 5-HT2B receptors is not a class effect of the ergolines.
Jähnichen S; Horowski R; Pertz HH
Eur J Pharmacol; 2005 Apr; 513(3):225-8. PubMed ID: 15862804
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the molecular fragment that is responsible for agonism of pergolide at serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A receptors.
Görnemann T; Hübner H; Gmeiner P; Horowski R; Latté KP; Flieger M; Pertz HH
J Pharmacol Exp Ther; 2008 Mar; 324(3):1136-45. PubMed ID: 18096760
[TBL] [Abstract][Full Text] [Related]
3. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
Kekewska A; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2011 Jul; 338(1):381-91. PubMed ID: 21518772
[TBL] [Abstract][Full Text] [Related]
4. Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
Schurad B; Horowski R; Jähnichen S; Görnemann T; Tack J; Pertz HH
Life Sci; 2006 Apr; 78(20):2358-64. PubMed ID: 16310806
[TBL] [Abstract][Full Text] [Related]
5. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
6. Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.
Hofmann C; Penner U; Dorow R; Pertz HH; Jähnichen S; Horowski R; Latté KP; Palla D; Schurad B
Clin Neuropharmacol; 2006; 29(2):80-6. PubMed ID: 16614540
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
8. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
Kelly CR; Sharif NA
J Pharmacol Exp Ther; 2006 Jun; 317(3):1254-61. PubMed ID: 16517693
[TBL] [Abstract][Full Text] [Related]
10. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
[TBL] [Abstract][Full Text] [Related]
11. Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline.
Platania CB; Leggio GM; Drago F; Salomone S; Bucolo C
Biochem Pharmacol; 2013 Nov; 86(9):1347-56. PubMed ID: 23962442
[TBL] [Abstract][Full Text] [Related]
12. Striking differences of action of lisuride stereoisomers at histamine H1 receptors.
Pertz HH; Görnemann T; Schurad B; Seifert R; Strasser A
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):215-22. PubMed ID: 17106670
[TBL] [Abstract][Full Text] [Related]
13. New central dopamine agonists.
Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):227-36. PubMed ID: 2999737
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
15. Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
Wong DT; Reid LR
Commun Psychopharmacol; 1980; 4(4):269-75. PubMed ID: 7273702
[No Abstract] [Full Text] [Related]
16. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
Jiang DH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909
[No Abstract] [Full Text] [Related]
17. Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery.
Kren V; Eich E; Pertz HH
Physiol Res; 2004; 53(1):35-43. PubMed ID: 14984312
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystal structure and conformational analysis of N-(3-dimethylaminopropyl)-N-(ethylaminocarbonyl)-6-(2-propenyl)er goline -8 beta-carboxamide (Cabergoline): comparison with bromocriptine and lisuride and a hypothesis for its high dopaminergic activity.
Sabatino P; Riva di Sanseverino L; Tonani R
Farmaco; 1995 Mar; 50(3):175-8. PubMed ID: 7755864
[TBL] [Abstract][Full Text] [Related]
19. 8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist.
Bakker RA; Weiner DM; ter Laak T; Beuming T; Zuiderveld OP; Edelbroek M; Hacksell U; Timmerman H; Brann MR; Leurs R
Mol Pharmacol; 2004 Mar; 65(3):538-49. PubMed ID: 14978232
[TBL] [Abstract][Full Text] [Related]
20. Role of low ouabain-sensitive isoform of Na+-K+-ATPase in the regulation of basal tone and agonist-induced contractility in ovine pulmonary artery.
Chanda D; Krishna AV; Gupta PK; Singh TU; Prakash VR; Sharma B; Joshi P; Mishra SK
J Cardiovasc Pharmacol; 2008 Aug; 52(2):167-75. PubMed ID: 18670362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
